Radiation Oncology

Mayo Clinic

Questions discussed in this category

Are there any circumstances where you recommend early institution of systemic therapy for patients with solitary plasmacytoma?

Specifically, do you offer closer follow-up for certain patients after local radiation?

3 Answers available

Papers discussed in this category

Blood, 2023 Nov 30

Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.

Cancer, 2011-10-01

Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy.

BMC Cancer, 2006 May 05

Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study.

International journal of radiation oncology, biology, physics, 1998-07-15

Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.

International journal of radiation oncology, biology, physics, 2006-01-01

Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients.

Blood, 2014 May 29

Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma.

Blood, 2014 Jun 17

Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis.

International journal of radiation oncology, biology, physics, 2011 Jan 27

Multi-institutional analysis of solitary extramedullary plasmacytoma of the head and neck treated with curative radiotherapy.

Related Topics in Radiation Oncology